axis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced it will present at the 15th Annual BIO CEO & Investor Conference on February 11th at 9:30am EST in the Basildon room at the Waldorf=Astoria in New York City. Thomas Moore, Chairman and CEO of Advaxis, will provide additional information on the Company’s Phase 2 study of ADXS-HPV in recurrent/refractory cervical cancer in 110 patients in India.
